ASX Healthcare Spotlight: Could ResMed (ASX:RMD) Be a September 2026 Stock to Watch?

Sonal Goyal

11 September 2026 04:05 PM AEST

ASX Healthcare Spotlight: Could ResMed (ASX:RMD) Be a September 2026 Stock to Watch?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

ResMed (ASX:RMD) remains a major healthcare technology company focused on sleep apnoea, respiratory care and digital health solutions.

The company operates globally, supplying medical devices and software solutions that support patients and healthcare providers. Its diversified Business model combines hardware products with recurring software-related Revenue streams.

Company Overview

ResMed designs and manufactures medical devices and digital health solutions focused on sleep and respiratory conditions.

Its products include continuous positive airway pressure (CPAP) devices, masks and ventilation solutions used in the treatment of sleep apnoea and other respiratory conditions.

The company also provides software solutions for healthcare providers, supporting patient management outside traditional hospital settings.

FY26 Performance

ResMed reported its fiscal 2026 results for the year ended 30 June 2026, highlighting continued growth across its operations.

Revenue increased to US$5.65 billion, while Net Income reached US$1.52 billion. The company also reported improved gross margins compared with the previous year.

The results reflected continued Demand for sleep and respiratory care products, along with contributions from its software business.

Business Growth

ResMed continues to focus on expanding access to sleep and respiratory care solutions globally.

The company’s device business remains supported by demand for sleep apnoea treatment products, while its software platforms provide additional support for healthcare providers and patient management.

The combination of medical devices and digital solutions remains central to ResMed’s Long-term Growth strategy.

Factors to Watch

Investors are expected to monitor demand trends for sleep and respiratory care products, software adoption and ongoing Margin performance.

Healthcare reimbursement policies, competitive developments and changes in patient treatment patterns may also influence future growth.

The company’s ability to continue innovation while managing operational costs will remain important.

Risks

ResMed operates in a competitive healthcare technology market where product innovation, regulatory approvals and reimbursement conditions can affect performance.

Changes in healthcare policies, Supply chain conditions and product-related issues may also influence operating outcomes.

The company’s international operations expose it to currency movements and varying healthcare environments.

Conclusion

ResMed continues to maintain a significant position in the global healthcare technology sector through its sleep, respiratory care and software businesses.

The company’s FY26 performance highlighted continued revenue growth and improving operational outcomes. Going forward, investors are likely to focus on healthcare demand trends, product innovation and the company’s ability to maintain growth across its global markets.

FAQs

Q: What does ResMed do?

A:ResMed develops medical devices and software solutions focused on sleep apnoea, respiratory care and healthcare management.

Q: What are ResMed’s main products?

A:ResMed’s products include CPAP devices, masks, ventilation solutions and healthcare software platforms.

Q: What were ResMed’s key FY26 financial results?

A:ResMed reported FY26 revenue of US$5.65 billion and net income of US$1.52 billion.

Q: What are the main risks for ResMed?

A:Key risks include healthcare regulation changes, competition, reimbursement conditions, supply chain challenges and product-related issues.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.